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Subthalamic nucleusDuring implantation of deep-brain stimulation (DBS) electrodes in the target structure, neurosurgeons and neu-
rologists commonly observe a “microlesion effect” (MLE), which occurs well before initiating subthalamic DBS.
This phenomenon typically leads to a transitory improvement of motor symptoms of patients suffering from
Parkinson3s disease (PD). Mechanisms behindMLE remain poorly understood. In this work, we exploited the no-
tion of ranking to assess spontaneous brain activity in PD patients examined by resting-state functional magnetic
resonance imaging in response to penetration of DBS electrodes in the subthalamic nucleus. In particular, we
employed a hypothesis-free method, eigenvector centrality (EC), to reveal motor-communication-hubs of the
highest rank and their reorganization following the surgery; providing a unique opportunity to evaluate the di-
rect impact of disrupting the PDmotor circuitry in vivowithout prior assumptions. Penetration of electrodes was
associated with increased EC of functional connectivity in the brainstem. Changes in connectivity were quantita-
tively related to motor improvement, which further emphasizes the clinical importance of the functional integ-
rity of the brainstem. Surprisingly, MLE and DBS were associated with anatomically different EC maps despite
their similar clinical beneﬁt on motor functions. The DBS solely caused an increase in connectivity of the left
premotor region suggesting separate pathophysiological mechanisms of both interventions. While the DBS
acts at the cortical level suggesting compensatory activation of less affected motor regions, the MLE affects
more fundamental circuitry as the dysfunctional brainstem predominates in the beginning of PD. These ﬁndings
invigorate the overlooked brainstem perspective in the understanding of PD and support the current trend to-
wards its early diagnosis.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).dent; DBS, deep-brain stimula-
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Deep-brain stimulation (DBS) is a rapidly evolving surgical strategy,
in which one or more electrodes are implanted in speciﬁc brain regions
to treat a variety of disabling neurological and psychiatric conditions.
Externally-generated electrical currents applied to the electrodes then
stimulate the surrounding brain tissue and eventually alleviate the
patients3 debilitating symptoms. While new applications and brain tar-
gets for DBS continue to emerge (Hariz et al., 2013), DBS of the subtha-
lamic nucleus (STN) or globus pallidus (GP) interna have – over the past
two decades (Miocinovic et al., 2013) – become well-established treat-
ment options formovement symptoms associatedwith Parkinson3s dis-
ease (PD).the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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phenomenon, already in the operating room while implanting the DBS
electrodes. Shortly after insertion of electrodes into the target structure,
and well before the actual DBS pulse-generator is switched on, motor
symptoms of many PD patients improve markedly. Such improvement
remains noticeable for a certain period after implantation (Derrey
et al., 2010; Koop et al., 2006; Singh et al., 2012), in some cases even
months (Kondziolka and Lee, 2004; Mann et al., 2009). A general
term, known as the “microlesion effect” (MLE), has been established
to designate this phenomenon. Based on prevailing schemes of func-
tional organization of the basal ganglia (DeLong, 1990), the MLE could
be attributed to the reduction of abnormal basal ganglia output by dis-
ruption of cells and/or ﬁbers in the STN and GP, that is, a mechanism
similar to targeted ablative lesioning therapy. In fact, pallidotomy and
subthalamotomy have been considered favored therapeutic approaches
for patients with advanced PD in countries incapable of providing DBS
treatment due to economical or technological limitations (Alvarez
et al., 2005). However, in contrast to the permanent and irreversible im-
pact of ablative surgery, DBS is considered a less destructive and more
adaptable method (Haberler et al., 2000). Above all, the action of the
MLE associated with implantation of the DBS electrodes is transient
and gradually fades within days or weeks. This suggests that apart
from the destruction of brain tissuewithin the electrode track, it reﬂects
other transient posttraumatic tissue reaction along or close to the elec-
trode. In particular, sharp leakage of neurotransmitters caused by dam-
aged synapses inﬂuencing the surrounding unaffected neurons and
post-operative collateral edema of brain matter around the electrode
is thought to play an important role in the MLE (Jech et al., 2012). Ap-
pearance of the MLE is remarkably beneﬁcial — is considered as an evi-
dent immediate sign of good placement of the DBS electrodewithin the
particular portion of the target structure (Maltete et al., 2008). Yet, the
mechanisms behind the MLE have not been understood.
We hypothesized that penetration of DBS electrodes in the STN has a
substantial impact on the low-frequency blood-oxygenation-level de-
pendent (BOLD) ﬂuctuations in the resting-state (rs)-fMRI signal,
which have been shown to be altered by PD (Jech et al., 2013; Kahan
et al., 2014; Mueller et al., 2013). Speciﬁcally, the invasive intervention
in combinationwith the utilization of a novel hypothesis-free analytical
method gave us a unique opportunity to assess the direct impact of the
physically disrupted STN on the rest of the abnormal motor circuitry
in vivo without prior assumptions. This approach could identify novel
anatomo-functional correlations accountable for improvement of
motor symptoms related to the MLE and, subsequently, provide new in-
sights into the functional organization of the humanbrain affected by PD.
2. Materials and methods
2.1. Subjects
Thirteen patients suffering from an akinetic-rigid variant of PD
(11 males/2 females, age: 52 ± 7 years (mean ± standard deviation),
disease duration since the ﬁrst symptoms: 13 ± 3 years, duration of
levodopa treatment: 9 ± 3 years) participated in the study after giving
their written informed consent. All patients had a sporadic type of dis-
ease including ﬁve patients with beginning of symptoms before
40 years of age. None of these young-onset PD patients was positive
for common genetic mutations potentially related to PD. All experimen-
tal procedures conformed to the Declaration of Helsinki, and the study
protocol was approved by the Ethics Committee of the General Univer-
sity Hospital in Prague, Czech Republic. All patients met the United
Kingdom Brain Bank Criteria for diagnosis of PD and were classiﬁed
into the akinetic-rigid subtype of PD (Schiess et al., 2000), and suffered
from motor ﬂuctuations and/or disabling dyskinesias associated with
long-term levodopa treatment. Further, all patients were referred for
STN DBS therapy and thereby underwent the implantation of both
DBS electrodes and the internal pulse generator.Patients expressing signs of dementia and/or depression based on
a standard psychiatric examination and neuropsychological testing
(Mini-mental State Examination, Mattis Dementia Rating, Beck Depres-
sion Inventory) were excluded from the study. One further patient was
excluded due to excessive involuntary movements extending to the
head during the scanning session, whichwas evaluated post-hoc by an-
alyzing realignment parameters of the data during the fMRI pre-
processing procedure. A detailed demographic and clinical description
of patients involved in the study is summarized in Table 1 and Supple-
mentary Table S1.
2.2. Surgical procedure
Implantation of the DBS apparatus consisted of two separate surgery
sessions: Insertion of the permanent quadripolar stimulation electrodes
(3386 Medtronic, Minneapolis, MN, USA) into the STN bilaterally and
implantation of the connection leads and the internal pulse generator
to the subclavical region. This study focused exclusively on the time
points preceding and immediately succeeding the ﬁrst surgery session
(i.e., pre-/post-implantation of electrodes), while the MLE was still
identiﬁable.
The methodology associated with implanting the DBS electrodes
and the internal pulse generatorwas identical to the one thoroughly de-
scribed elsewhere (Jech et al., 2012).
2.3. Magnetic resonance imaging
All MRI investigationswere performed at 1.5 T on aMagnetom Sym-
phony scanner (Siemens, Erlangen, Germany). fMRI was collected in a
10-min session with 200 volumes of functional brain images collected
using a T2*-weighted, gradient-echo-planar imaging (EPI) sequence
(ﬂip angle, FA= 90°; repetition time, TR= 3000 ms; echo time, TE=
51 ms, 31 axial slices, nominal in-plane resolution 3 × 3 mm2, slice
thickness at 4mm) sensitive to the BOLD effect. For display and registra-
tion purposes, high-resolution three-dimensional T1-weighted structur-
al data were acquired using a magnetization-prepared rapid acquisition
gradient-echo (MP-RAGE) sequence (FA= 15°; TR= 2140 ms; inver-
sion time, TI = 1100 ms; TE = 3.93 ms). In Session 2 (i.e., 0–3 days
post-implantation), T2-weighted images were additionally collected
using a turbo spin-echo sequence (TR = 5520 ms; TE = 86 ms;
slice thickness 4 mm) for evaluating the grade of the collateral edema
caused by the DBS electrode penetration. This particular imaging se-
quence markedly intensiﬁes the contrast of edema (appearing as
hyperintensities in resulting images; Fig. 1), which considerably eases
its detection and evaluation.
All safety risks related to potential interference of the staticmagnetic
ﬁeld, radio-frequency pulses, or magnetic ﬁeld gradient pulses and the
implantedmetallic DBS hardware were rigorously assessed, and associ-
ated technical precautions were diligently adhered to. The underlying
safety standards employed for this evaluation have been published in
more detail elsewhere (Jech et al., 2012).
2.4. Experimental protocol
Patients were instructed to look at a ﬁxation cross on a projector
screen while remaining still in a supine position during scanning. Two
MRI examinations were carried out: (DBS OFF1) pre-implantation of
DBS electrodes (‘Session 1’; 18 ± 17 days before implantation) and
(DBS OFF2) post-implantation of DBS electrodes (‘Session 2’; 1 patient
scanned on the day of surgery, 11 patients one day after surgery, and
1 patient 3 days after surgery). In order to uncouple the effect of elec-
trode penetration from the therapeutic effects of levodopa and DBS,
anti-Parkinsonian medication was withdrawn at least 12 h before
bothmeasurement sessions and the chronic DBS was not yet initialized.
In both sessions (pre- and post-implantation), resting-state fMRI data
sets (‘DBS OFF1’ and ‘DBS OFF2’, respectively) were acquired as
Table 1
Summary of demographic and clinical details of the 13 patients included in the study.
ID G Age DD LD s1OFF s2OFF s3OFF s3ON s4ON CE SE DT DF
1 M 63 15 13 21 25 39 23 8 3 0.5 17 1
2 M 53 11 7 45 32 42 19 17 0.5 1 3 1
3 M 53 12 10 37 29 38 12 11 2 0.5 39 0
4 M 45 14 6 47 28 45 16 10 1 0 59 1
5 M 64 13 8 31 21 39 21 19 3 1 31 1
6 M 53 12 9 43 24 43 10 11 4 3 3 1
7 M 49 13 12 65 40 54 9 7 5 4 4 3
8 M 55 12 9 46 24 31 16 7 4.5 3.5 38 1
9 M 60 14 14 18 19 28 17 – 1 0 3 1
10 F 42 9 6 33 27 28 11 13 2 1 10 1
11 M 55 19 15 35 14 32 20 19 5 3 3 1
12 M 43 9 7 34 35 40 20 22 1.5 1 17 1
13 F 50 10 6 19 17 29 20 13 4.5 3.5 10 1
Mean – – 52.7 12.5 9.4 34.2 25.8 37.5 16.5 12.3 2.8 1.7 18.2 1.1
SD – – 7.0 2.7 3.2 9.9 7.3 7.7 4.6 4.2 1.7 1.5 18.0 0.6
Age is in years; CE — rating of cortical edema; DD — duration of the disease (years); DF— days after surgery to post-operative fMRI scan (days from surgery); DT— days between pre-
implantation of fMRI scan and electrode implantation (days to surgery); G— gender (M—male/F— female); ID— patient3s identiﬁcation number; LD— duration of levodopa treatment
(years); s1OFF—UPDRS-III score in theﬁrst scanning session offmedication (pre-implantation); s2OFF—UPDRS-III score in the second scanning session offmedication and off stimulation
(0–3 days post-implantation); s3OFF—UPDRS-III score in the thirdmeasurement session offmedication and off stimulation (~1month post-implantation); s3ON—UPDRS-III score in the
third session off medication and on stimulation (approx. 1 month post-implantation); s4ON — UPDRS-III score in the fourth measurement session off medication and on stimulation
(approx. 1 year post-implantation); SE — rating of subcortical edema and SD— standard deviation.
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were tested at the end of ‘Session 2’ through the implanted electrodes
using the identical rs-fMRI protocol (‘DBS ON’). A Dual Screen 3628 ex-
ternal stimulator (Medtronic, Minneapolis, MN, USA) was kept outside
the MR scanner and connected to externalized leads of the electrodes
with a 4-m extension cable that was used for DBS in a bipolar setup
with parameters eliciting clear clinical improvement (mean amplitude:
2.64 ± 0.44 V, pulse duration: 60 µs, pulse frequency 130 Hz). Due to
technical reasons, two separate rs-fMRI acquisitions were made during
unilateral left and unilateral right neurostimulation (in random order)
each lasting up to 15 min.
2.5. Evaluation of motor symptoms
Severity of patients3 PD motor symptoms was assessed off medica-
tion using the UPDRS-III score by a movement disorder specialist (R.J.)
prior to every rs-fMRI measurement (Sessions 1 and 2). The UPDRS-IIIFig. 1. T2-weighted MR images demonstrating collateral edema caused by the DBS electrode in
rating 3.5; patient 8). The edema appears as hyperintensity (indicated by arrows), while the
stimulation; L — left and R — right.score off medication was also evaluated in two additional post-
operative sessions without fMRI scanning: ‘Session 3’ approximately
1 month after surgery, immediately preceding the initiation of chronic
DBS treatment by the internal pulse generator at optimal settings with
DBS both off and on; and ‘Session 4’ (with the exception of one patient)
at a later post-operative phase 1 year after implantation during active
DBS when optimal stimulation parameters were reached. T2-weighted
images were also collected during Session 4 at the latter post-
operative stage 1 year after implantation for edema assessment (with-
out the fMRI measurement).
The UPDRS-III score and the hemibody, axial, akinesia, rigidity, and
tremor subscores were systematically extracted from the UPDRS-III
score sheets for more elaborate, symptom-driven fMRI analyses
(Holiga et al., 2013) (see the fMRI analyses section). To assess changes
in patients3 motor symptoms severity pre- and post-implantation, the
UPDRS-III score was evaluated using a repeated measures analysis of
variance (rm-ANOVA). Prior to rm-ANOVA statistics, the Shapiro–Wilksertion at the cortical (left panel; rating 5; patient 7) and subcortical levels (right panel;
DBS electrode artifacts are hypointense. MR — magnetic resonance; DBS — deep-brain
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verify the assumptions of normality and sphericity in the distribution
of data. Post-hoc analysis was performed in order to reveal signiﬁcant
UPDRS-III changes between particular measurement sessions (i.e., pre-
implantation, 0–3 days post-implantation, 1 month post-implantation,
1 year post-implantation).
2.6. Edema assessment
The grade of collateral edema associated with penetration of the
electrodes was evaluated individually by an average semi-quantitative
rating of two blinded raters in both cortical (affecting the white matter
just beyond the cortex) and subcortical regions (affecting deep struc-
tures and adjacent white matter) for each hemisphere separately. This
evaluation was performed by assessing T2-weighted MR images ac-
quired during Session 2 (Fig. 1). We adopted the rating scale from our
previouswork (Jech et al., 2012). Brieﬂy, the higher the rating, the larger
the area of detected cortical/subcortical edema (range 0–6 for each),
with 0 representing no collateral edema around the electrodes.
2.6.1. fMRI analyses
The data were pre-processed using the statistical parametric map-
ping (SPM8) software package patched to revision 4667 (Wellcome
Trust Centre for Neuroimaging, UCL, London, UK), Matlab (R2010b,
MathWorks Inc., Natick, MA, USA) and LIPSIA software package
(Lohmann et al., 2001). A standard pre-processing of fMRI datawas per-
formed including realignment, slice-time correction, normalization to
the Montreal Neurological Institute (MNI) template, spatial ﬁltering
using an 8-mm full-width-at-half-maximum three-dimensional Gauss-
ian kernel, and a temporal ﬁltering using a band-pass ﬁlter passing the
frequencies within a range of 0.0125–0.2 Hz.
The motion parameters obtained from the SPM realignment proce-
dure (three translational; three rotational) were further investigated
for differences of motion in the pre- and the post-implantation states.
2.6.2. Eigenvector centrality (EC) mapping
In the currentwork,we assessed the effect of the STNmicrolesion on
PD brain networks by means of functional connectivity, that is, correla-
tions of BOLD signal ﬂuctuations between distal brain regions over the
course of an rs-fMRI session recorded in the absence of experimental
stimulation or task (Fox and Raichle, 2007; Zhang and Raichle, 2010).
The inability to extract the MRI information from the DBS target region
itself – due to magnetic susceptibility artifacts caused by the implanted
metallic electrodes – disallowed us to assess the connectivity of
the disrupted STN directly. Therefore, in contrast to conventional
hypothesis-driven rs-fMRI experiments, where a seed region of interest
is speciﬁed a priori (Buckner et al., 2013), we employed EC (Lohmann
et al., 2010) as an assumption-free, hypothesis-independent explorato-
ry method based on graph theory (Bullmore and Sporns, 2009, 2012).Fig. 2.Data-drivenmasking procedure based on image intensity thresholding to account formag
Various image intensity thresholds ranging from 0.25 to 0.50 were used for qualitative assessm
masks are overlaid on an average normalized fMRI obtained in the post-surgery sessions. DBSThesis of EC was already established at the beginning of the 20th
century and has been continuously exploited in various contexts ever
since (e.g., in the context of ranking webpages, scientiﬁc journals,
or economic sectors) (Franceschet, 2011). By using EC mapping
(Lohmann et al., 2010), these iterative constructs are extrapolated into
the world of functional connectivity and rs-fMRI. Subsequently, we in-
vestigated spatial reorganization of central brain regions – in the current
case,motor communication hubs – following the penetration of theDBS
electrodes and subsequent stimulation in the STNs of 13 patients suffer-
ing from advanced PD.
The foundation of EC is a similaritymatrix (encompassing ameasure
of goodness of some kind)— in our case an n × n symmetric correlation
matrix,X (where n represents the number of voxels). The entries of this
matrix denote correlations between fMRI timecourses of a particular
pair of voxels. In mathematical terms, EC of a voxel xi is deﬁned as the
ith entry in the normalized eigenvector belonging to the largest eigen-
value of X. To ensure the uniqueness and non-negativity of the largest
eigenvalue and associated eigenvector components by the Perron–
Frobenius theorem, the correlation matrices were rescaled prior to EC
calculations by adding one to each element of the matrix. We refer the
reader to the publication by Lohmann et al. (2010) for a more formal
and detailed description of EC mapping for fMRI. Using the LIPSIA soft-
ware package (Lohmann et al., 2001), we calculated the individual ei-
genvectors (EC maps) for each patient and measurement session
separately (i.e., Sessions 1 and 2, pre-/post-implantation of electrodes).
In other words, we used the iterative character of EC to identify the
most central communication hubs – regions functionally connected
with many other central regions – in the motor system of each patient
pre- and post-surgery. Importantly, the EC calculations were restricted
to regions masked in a search space comprising the motor system spe-
ciﬁcally (Fig. 3b; premotor, motor and sensory cortices, basal ganglia,
brainstem, and cerebellum) based on a WFU PickAtlas standard
human brain atlas (Maldjian et al., 2003), to restrain EC contributions
of areas of no interest presumably affected by the experimental para-
digm (e.g., visual system). In addition, fMRI voxels exhibiting severe
magnetic susceptibility artifacts caused by the presence of the DBS ap-
paratus in the static magnetic ﬁeld were excluded from the search
space used in all subsequent analyses and statistics. In particular, a qual-
itative approach was adopted based on thresholding of individual post-
surgery, distorted fMRI data. Various intensity cutoff-thresholds ranging
from 0.25 (liberal) to 0.50 (conservative) with a step size of 0.1 were
used to generate a group, data-driven mask for EC calculations. Fig. 2
demonstrates the approach by depicting various intensity thresholds
that were employed for the qualitative assessment of the resulting
masks.
Clearly, liberal thresholding (0.25) results in a mask incorporating
regions around the STN affected by electrode-induced artifacts. In con-
trast, a threshold of 50% is overly conservative and eliminates a consid-
erable portion of artifact-free brain areas. After visual inspection, anetic susceptibility artifacts caused by themetallic DBS electrodes and the pulse generator.
ent of the artifacts and formation of the search space for subsequent ECM calculations. The
— deep-brain stimulation and ECM— eigenvector centrality mapping.
Fig. 3. Impact of DBS electrode implantation in the STN on motor networks of 13 patients suffering from PD in the absence of medication and with DBS switched off. (a) UPDRS-III scores
indicating alleviation of PD motor symptoms in the acute phase of microlesion followed by a relapse to the pre-operative levels in the latter stages after implantation. In addition, effect
of STN DBS is shown in gray bars 1 month and 1 year after implantation. The bars showmean, ﬁrst/third quartile, and lower/upper adjacent values. (b) Outlined search space (region-of-
interest) used for EC calculations and subsequent statistics comprising the entire motor system of the brain overlaid on a standardized stereotactic brain. (c) Reorganization of central
motor communication hubs due tomicrolesion effect following the DBS electrode penetration in the STN. The brainstemwas identiﬁed as the central functional connectivity hub sensitive
to microlesion. Summary of obtained statistics is shown in Table 2. 0–3 d— days 0–3; 1 m— 1 month; 1 year— 1 year; DBS— deep-brain stimulation; EC— eigenvector centrality; FDR—
false discovery rate; L — left; LBs— lower brainstem; MLE — microlesion effect; PD — Parkinson3s disease; Post — post-implantation stage(s); Pre — pre-implantation stage; R — right;
STN — subthalamic nucleus; UBs — upper brainstem; and UPDRS-III — motor part of the Uniﬁed Parkinson3s Disease Rating Scale; **— p b 0.01; *** — p b 0.001.
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data-driven mask. The ﬁnal mask was then formed as a conjunction be-
tween the anatomical search space and the intensity-thresholdedmask.
Of note, the resulting parametric maps remained identical regardless of
the selected data-driven masking threshold, which suggests that the
magnetic susceptibility artifacts did not affect the correlation patterns
identiﬁed by ECM.
To reveal reorganization of themost important communication hubs
related to the insertion of electrodes across the group of patients,
a group analysis in the form of a paired t-test (EC maps post-implantation, off stimulation — EC maps pre-implantation) was per-
formed. The effects of age, disease duration, and levodopa treatment du-
ration were also investigated using additional covariates in the
statistical model. Here, we computed the interaction between these fac-
tors and the effects of electrode penetration to exclude a different corre-
lation between the covariates and EC in the pre- and post-implantation
states. To disentangle the microlesion-related functional reorganization
from actual DBS effects, we also computed a paired t-test between the
DBS ON and DBS OFF2 state. An uncorrected voxel-level threshold of
p b 0.005 was adopted with a post-hoc cluster-size adjustment to
Table 2
Summary of signiﬁcant group EC differences related to penetration of DBS electrodes in
the STN (i.e., contrast = post-implantation− pre-implantation).
Structure PFDR‡ k punc t x y z
Upper brainstem 0.041 62
Maximum 1 2.7·10−5 6.10 −3 −28 −17
Maximum 2 0.002 3.45 −15 −31 −17
Lower brainstem (left) 0.019 88
Maximum 1 8.1·10−5 5.39 −12 −37 −41
Maximum 2 5.1·10−4 4.31 −9 −43 −50
Maximum 3 0.002 3.52 −18 −43 −50
Lower brainstem (right) 0.475a 21
Maximum 1 2.0·10−4 4.84 9 −34 −41
Maximum 2 4.5·10−4 4.38 15 −37 −50
Bold typeface letters denote obtained clusters and associated statistics at the cluster-level,
while nested standard typeface letters are related to statistical values of the local maxima
(at the voxel-level) identiﬁedwithin the respective cluster. DBS— deep-brain stimulation;
EC — eigenvector centrality; k — number of signiﬁcant voxels within the cluster; MNI —
Montreal Neurological Institute; pFDR‡ — alpha value corrected for multiple tests at clus-
ter-level using false discovery rate correction; punc— uncorrected alpha value; STN— sub-
thalamic nucleus; t — peak t-statistic; [x, y, z] — coordinates of corresponding voxel in
MNI-template anatomical space in millimeters;
a The right brainstem cluster did not survive the FDR cluster-level correction.
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ery rate (FDR) correction at pFDR b 0.05. This particular alpha level was
used in all subsequent analyses.
A more conventional seed-based approach was also performed to
demonstrate the “destination” regions driving the ECM changes caused
by theMLE. The peak voxel identiﬁed by the paired t-test was used as a
seed voxel. Correlations between timecourses of the seed region and the
rest of the brain were calculated in pre- and post-surgery data. The cor-
relation maps were transformed using Fisher r–z transformation and a
paired t-test was calculated using a “post–pre” contrast.
To disentangle the microlesion-related reorganization of intrinsic
activity from the actual DBS effects, we also performed a statistical anal-
ysis assessing potential differences between EC obtained within the
post-implantation sessions. Here we used a ﬂexible-factorial model
containing the EC of all three measurements of the post-implantation
session (DBS OFF, left STN DBS ON, right STN DBS ON). The ﬁnal contrast
was set to check for signiﬁcant EC response to DBS.
Additionally, a linear regression group model was ﬁtted to discover
potential linear relationships between the EC maps and the particular
UPDRS-III scores/sub-score (hemibody, axial, akinesia, rigidity, tremor)
(Holiga et al., 2013), but also edema ratings, irrespective of the stage of
surgery. A dot-plot was formed to illustrate the linear relationship be-
tween adjusted EC response at a speciﬁc brain coordinate and the
UPDRS-III score for eachpatient/stage (13 patients × 2 stages). Thereup-
on, coefﬁcient of determination (R2) was calculated to quantify the pro-
portion of variance explained by the model.
3. Results
3.1. Clinical scores
The motor part of the Uniﬁed Parkinson3s Disease Rating Scale
(UPDRS-III) score differed substantially across themeasured timepoints
pre- and post-surgery (Fig. 3a). It dropped signiﬁcantly (p = 0.009;
F(1,12) = 9.5) from 34.2 ± 9.9 (mean ± standard deviation) in the
ﬁrst measurement session (3–59 days pre-surgery, off medication) to
25.8 ± 7.3 in the second measurement session (0–3 days post-
surgery, off medication, off stimulation) evidencing the therapeutic
beneﬁt of the electrode penetration and, thereby, demonstrating the
MLE itself. In the third measurement point (approx. 1 month after sur-
gery, before the initiation of chronic DBS treatment), the UPDRS-III in
absence of stimulation leveled up with the UPDRS-III in the pre-
operative level, thus no signiﬁcant difference could be found between
them (p= 0.228). In particular, the score increased to 37.5 ± 7.7, indi-
cating the transitory character of theMLE and its eventual deterioration
over a period of 1month. Immediately after initiation of the stimulation
1 month after implantation (off medication), the score improved to
16.5 ± 4.6 (p= 2.6 × 10−4; F(1,12) = 26.1 compared to the ﬁrst ses-
sion; p = 7.0 × 10−6; F(1,12) = 56.6 compared to the third session),
documenting the success of the surgical intervention and the remark-
able therapeutic beneﬁt of DBS in the study group, even at the initial
stages of chronic DBS treatment. In the fourth measurement session
(approx. 1 year upon chronic DBS treatment), the UPDRS-III off medica-
tion decreased even further to 12.3 ± 4.2 (p=0.014; F(1,11) = 8.5) in
comparison to the measurement taken immediately after initiation of
DBS (approx. 1 month after surgery), conﬁrming the beneﬁcial long-
term character of the DBS treatment and correctness of electrode
placement.
3.1.1. Edema
Penetration of the DBS electrodes caused acute collateral edema
along the track of the electrodes (Fig. 1). The edema was assessed in
the ﬁrst post-operative stage (0–3 days after surgery). Subcortical and
cortical edemas were rated at 1.7 ± 1.5 and 2.8 ± 1.7, respectively
(range 0–6). No signiﬁcant left-/right-side edema differences were
found in either cortical or subcortical structures. One month afterimplantation, the edema gradually vanished, as indicated by UPDRS-III
scores, which returned to pre-operative levels (Fig. 3a). No signs of
edema were detected 1 year post-implantation, suggesting that edema
is a principal mechanism contributing to the beneﬁcial effect of DBS
electrode penetration.
3.1.2. Motion inside the scanner
The analysis of the motion variables did not show a signiﬁcant
difference between the subject3s motion in the pre- and the post-
implantation state including the mean, the standard deviation, and the
maximum of the six motion parameters (p N 0.05, uncorrected).
3.1.3. Eigenvector centrality mapping
The contrast of potentialmicrolesion effects (post-implantation,DBS
OFF2–pre-implantation, DBS OFF1) showed a signiﬁcant increase of EC
due to electrode penetration in the upper and lower brainstem
(Fig. 3c; Table 2); forming the main intrinsic communication hub
responding to the penetration of electrodes. The result was not affected
by including age, disease duration, and treatment duration as additional
covariates. The interaction analysis between these covariates and the
pre- and post-implantation state did not show any signiﬁcant effect.
The reversed contrast (i.e., pre-implantation, DBS OFF1–post-implanta-
tion,DBS OFF2) did not reveal any signiﬁcant EC reduction after implan-
tation of electrodes. In addition, EC inversely correlated with UPDRS-III
scores in the upper and lower brainstem, irrespective of the surgery
stage (Fig. 4a and b). No relationship was found between the EC maps
and the edema ratings.
Conventional seed-based approach revealed signiﬁcantly increased
synchronization between the brainstem peak and several cerebellar re-
gions (Fig. 5). For the DBS ON (conjunction analysis from unilateral left
and unilateral right neurostimulations) compared to the DBS OFF2
state, there was an increase of EC in the left premotor cortex (Fig. 5).
In addition, EC inversely correlated with UPDRS-III scores in the left
premotor cortex, irrespective of the session (Fig. 6a, b and c).
4. Discussion
4.1. Study overview
In this study, we assessed the effects of DBS electrode penetration in
brains of patients undergoing STNDBS surgery to determinehow the in-
vasive surgical procedure alone alters the function of motor circuitry in
PD, and to identify the mechanisms responsible for the considerable
motor improvement that patients experience in the acute phase of
Fig. 4. Statistical maps of the voxel-wise negative correlations between EC and motor symptoms of 13 patients regardless of the implantation stage (i.e., the better the clinical picture of
patients, the higher the EC in a particular brain region). UPDRS-III scores signiﬁcantly inversely correlatedwith the EC of the (a) upper and (b) lower brainstem. Bottom graphs denote the
particular linear relationship in a respective voxel coordinate indicated by a blue cross. EC responses are ﬁtted, normalized, and displayed as blue dots. The light blue dots indicate the EC
responses plus errors. EC— eigenvector centrality; FDR— false discovery rate; R2— coefﬁcient of determination; andUPDRS-III—motor part of theUniﬁedParkinson3s Disease Rating Scale.
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had an eminent impact on the intrinsic activity of the motor system as
evaluated by correlations of spontaneous low-frequency BOLD ﬂuctua-
tions measured by rs-fMRI. The major ﬁnding was the identiﬁcation of
the brainstem as the principal hubwith increased centrality of function-
al connectivity following the electrode penetration (Fig. 3c; Table 2),
and as the region particularly recruited in the amelioration of the
motor symptoms (Fig. 4a and b).
4.2. Role of the brainstem
Signiﬁcant contribution of the brainstem in PD pathology was
already established six decades ago (Eadie, 1963; Greenﬁeld andBosanquet, 1953) andwas corroborated by amore recent diligent histo-
pathological study of Braak et al. (2003)who recognized the importance
of the brainstem pathology especially in the initial, prodromal phases of
the disease (Snyder et al., 2013; Tison and Meissner, 2014). Strikingly,
closed-loop subcortical projections linking the brainstem structures
with the basal ganglia were proposed and regarded as phylogenetically
older than the well-known cortical–basal ganglia–cortical connectional
architecture (McHafﬁe et al., 2005), whichmight indicate the potential-
ly paramount signiﬁcance of the brainstem structures in the disease
pathogenesis. A recent study has conﬁrmed this proposal; speciﬁcally,
in addition to ascending dopaminergic projections from substantia
nigra pars compacta and/or ventral tegmental area to basal ganglia, de-
scending projection to mesencephalic locomotor region – a brainstem
Fig. 5. Seed-based correlation differences caused by penetration of the DBS electrodes in the STN. Insertion of electrodes caused increased synchronization between the brainstem and the
cerebellum. EC — eigenvector centrality; FDR— false discovery rate; MLE—microlesion effect; STN—subthalamic nucleus; and UPDRS-III — motor part of the Uniﬁed Parkinson3s Disease
Rating Scale.
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et al., 2013). Also, dopaminergic innervation of pedunculopontine nu-
cleus (PPN), another part of the brainstem (role of PPN in PD is reviewed
in Pahapill and Lozano (2000)), was observed in monkeys with its
radical reduction after intoxication with MPTP (1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine) — a primate model of PD (Rolland et al.,
2009). These and other (Grinberg et al., 2010) anatomo-pathological
substrates for brainstem and basal ganglia interactions therefore repre-
sent a solid basis for the ﬁndings presented in the current study.
Recently, there have been radical changes in the current concepts of
structural and functional roles of cerebellar circuits, by recognizing ana-
tomical substrates for cerebellum inﬂuencing thebasal ganglia and vice-
versa, and by observing that cerebellar output is affecting generation
and control of movement at the motor cortex levels (Bostan et al.,Fig. 6. EC change related to acute DBS. (a) Treating the patients with unilateral STN DBS increas
(b) Correlation of left STNDBSwith theUPDRS-III scores. (c) Correlation of right STNDBSwith t
discovery rate; STN — subthalamic nucleus; UPDRS-III— motor part of the Uniﬁed Parkinson3s2013). A review byWu and Hallett (2013) signiﬁes the considerable in-
volvement of cerebellum in PD. It is speculated to exert both patholog-
ical and compensatory effects, though the current knowledge about its
role in PD pathophysiology remains rather limited (Wu and Hallett,
2013).
Our results suggest that the brainstem – by signiﬁcantly inﬂating
centrality of connectedness and increasing synchronization with the
cerebellum – acts as a compensatory hub supporting the disrupted
motor network to maintain relatively normal motor function in the
acute phase of microlesion. The roles of the brainstem and the cerebel-
lum, however, do not seem to be exclusively supportive and compensa-
tory. Results from recent rs-fMRI studies investigating intrinsic brain
activity of PD patients also clearly imply integration of the brainstem
and the cerebellum in the disease pathophysiology and its treatment.ed EC in the PMC. Data from left and right unilateral stimulationwere pooled in themodel.
he UPDRS-III scores. DBS— deep-brain stimulation; EC— eigenvector centrality; FDR—false
Disease Rating Scale.
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was revealed in patients with PD (Jech et al., 2013). Also, reductions in
the brainstem3s functional connectivity with the striatum were identi-
ﬁed in PD patients as compared to healthy subjects (Hacker et al.,
2012). Seed-based analyses of striatal networks revealed increased
functional connectivity of the cerebellum with putamen following the
dopaminergic challenge (Kelly et al., 2009). Further, decreased striatal
functional connectivity of cerebellum was observed in PD patients as
compared to healthy subjects (Hacker et al., 2012) and pathological
functional connectivity interactions between cerebellothalamic and
basal ganglia circuits were also reported in tremor-dominant PD pa-
tients (Helmich et al., 2011). These ﬁndings indicate direct involvement
of the brainstem and the cerebellum in degenerated dopaminergic net-
works and point to their signiﬁcant contribution to PD-related patho-
logical processes. This reinforces the relevance of our ﬁnding (Fig. 3c;
Table 2) that the brainstem constitutes a central communication hub
and, by increasing its functional connectivity with the cerebellum, par-
ticularly supports the physically-disrupted motor system during the
acute phase of microlesion in PD. However, the brainstem also simulta-
neously renders pathological effects, as documented by the signiﬁcant
linear association of the motor symptoms of the disease with the
brainstem3s EC (Fig. 4a; Fig. 4b). Therefore, we speculate that the central
role of the brainstem may include two overlaying perspectives — com-
pensatory and pathological.
As mentioned earlier, Braak et al. (2003) observed that the neural
damage does not spread randomly in the human brain affected by PD,
but rather follows a predetermined spatio-temporal sequence within
distinct stages, beginning in the lower brainstem — the medulla
oblongata in the presymptomatic phase (stages 1–2), ascending to pon-
tine tegmentum and midbrain, when the ﬁrst motor symptoms appear
(stages 3–4), and eventually converging in the neocortex with the
emergence of non-motor symptoms (stages 5–6). This emphasizes the
importance of the lower brainstem pathology in the disease progres-
sion, especially in its presymptomatic phases, when the magnitude of
neural loss is still minimal, no motor symptoms are apparent, hence
the chances of discovering putative disease-modifying therapies,
which would eventually halt the disease progression, are higher
(Goedert et al., 2013; Tison andMeissner, 2014). The brainstem regions
therefore have the uttermost potential to deliver preclinical markers of
the disease and are predisposed as the potential target for testing novel
neuroprotective agents or brain stimulation techniques (Abbott, 2005;
Pahapill and Lozano, 2000). Research attempts should therefore shift
from the striatal dogma towards earlier, premotor phases of the disease
and turn appropriate attention to the overshadowed brainstem. The
work presented here demonstrates that the EC of intrinsic activity as
measured by rs-fMRI correlations is capable of detecting changes even
in the lower brainstem structures and thus might be a potential candi-
date for premotor biomarkers of the disease.4.3. Previous imaging studies of the STN microlesion
Our previous work revealed signiﬁcantly decreased amplitude
of ﬁnger-tapping-related BOLD response in several areas including
precentral gyrus, supplementary motor area, rolandic operculum,
insula, thalamus, and GP/putamen following the implantation of elec-
trodes in the STN (Jech et al., 2012). Although intriguing, comparing
the current rs-fMRI and previous task-based fMRI observations does
not provide much room for interpretation, as the relationship between
intrinsic low-frequency BOLD ﬂuctuations and evoked task-based
BOLD activity is not entirely known (Fox et al., 2005; Smith et al., 2009).
Models of the relationship between functional connectivity and en-
ergy consumption have been, on the contrary, recognized recently
(Tomasi et al., 2013), proposing a non-linear power scaling of the de-
gree of connectivity and glucosemetabolism in the human brain. There-
fore, it is critical to note that no correspondence has been identiﬁedbetween presently observed EC changes and previously reported FDG-
PET changes (Pourfar et al., 2009) related to the STN microlesion. It
is important to point out the dissimilar experimental designs used
within the studies, which could have caused the dichotomous observa-
tions. While in our study, brain data were acquired 0–3 days post-
implantation from 13 DBS-naïve, akinetic-rigid PD patients, Pourfar
et al. (2009) performed PET scanning at an average of 20 months
post-operatively on 6 patients of unknown PD subtypewho had already
undergone chronic DBS treatment. Although Pourfar et al. controlled for
the implantation-to-scanning-period variance in their statistical analy-
ses, this might have been insufﬁcient to account for confounds likely
inﬂuencing the results, e.g., the action of transient collateral edema, or
the potential short-term impact of chronic DBS treatment introducing
consequent after-effects in absence of stimulation.
4.4. Relation to DBS
Interestingly, an increase of EC in the premotor cortexwas identiﬁed
in the same group of patients in response to the STN DBS treatment bi-
laterally (Mueller et al., 2013), although an increase of ECwasmore pro-
nounced in the left premotor cortex. Eigenvector centrality correlated
with UPDRS-III scores, indicating clinical effects of the functional con-
nectivity changes. These effects might be transmitted by the so-called
hyperdirect pathway between STN and cortical motor areas as shown
by connectivity analyses in healthy subjects (Brunenberg et al., 2012).
Taken together, these data and our present results do not suggest an
overlying intrinsic brain connectivity mechanism in MLE and DBS. Sur-
prisingly, while DBS of STN seems to act (with regard to EC) at the cor-
tical levels only, sole penetration of electrodes caused functional
connectivity changes only in ventral posterior regions of the brain. It is
noteworthy that the fMRI scans in both cases were taken in the acute
phase of microlesion, before the chronic treatment with the DBS was
initiated. It seems that the mechanisms behind acute microlesion did
not directly contribute to the DBS response, as no signiﬁcant interaction
has been found between the EC responses of the two clinical interven-
tions. Nevertheless, the results of Mueller et al. (2013) clearly reconcile
with the simple model of STN inhibition leading to an increase in corti-
cal activation (Ballanger et al., 2009).
4.5. Limitations of the study
EC mapping has a major advantage over other data-driven ontol-
ogies as independent component analysis (ICA). While ICA requires as-
sumption on the number of components to be used, which can result in
some complications (Zhang and Raichle, 2010), no a priori information
is needed before EC is performed. This is likely to be advantageous in
view of substantial distortion artifacts and signal voids in the fMRI
data acquired with echo planar imaging (EPI) due to a strong gradient
in the local magnetic susceptibility (and, hence, magnetic ﬁeld inhomo-
geneity) in the vicinity of the DBS electrodes and the unknown effect of
these artifacts on the known functional networks. However, voxels
exhibiting very low signal (STN, premotor cortical areas) needed to be
excluded from the EC mapping search space, together with a consider-
able portion of brain not assumed to be involved in motor aspects of
PD pathophysiology. This might have resulted in missing certain cen-
trality patterns relevant for PD. Speciﬁcally, excluding voxels of the
disrupted, later stimulated, thus clearly the most essential part of the
network – STN – possibly resulted in decreased sensitivity to detect
hubs interconnected with it. Further, EC does not reveal the directional-
ity of functional connectivity and is unable to uncover interactions be-
tween identiﬁed hubs, thus no causal description of intrinsic activity
differences could be derived.
Low resolution of MR images acquired at 1.5 T consequently limited
the inspection of potential mechanisms behind the MLE on a rather
coarse spatial scale. More detailed analyses with much greater spatial
accuracy are needed to attribute the action of the MLE to certain
273Š. Holiga et al. / NeuroImage: Clinical 9 (2015) 264–274physiological processes (i.e., conﬁrming leakage of neurotransmitters or
observing transitory mechanisms of edema). The insufﬁcient resolution
of the images also disallowed us to localize the centrality changes with-
in the brainstem3s internal architecture precisely.
Complicated surgical procedures and associated ethical constraints
restricted us in randomizing the experimental design properly. Speciﬁ-
cally, there was almost no variance in implantation-to-measurement
time, which limited us in studying the edema spreading over time and
observing its direct contribution to the MLE in more detail.
5. Conclusion
The invasive intervention in combination with the hypothesis-free
analytical method of ECM provided uswith a unique opportunity to ob-
serve the direct and cardinal impact of dysfunctional STN on the resting
motor-circuitry in PD patients in vivo. Despite the similar beneﬁt on
motor functions, the transitory MLE and DBS were associated with ana-
tomically different patterns of resting functional connectivity.While the
DBS propagates to premotor areas suggesting compensatory activation
of less affected cortical regions, theMLE affects the fundamental circuit-
ry itself as the brainstemdysfunction predominates since the early stage
of PD. TheMLE-related activation of the brainstem and cerebellum pre-
sumably compensates for the disrupted neurons to maintain relatively
normal motor function in the acute phase of MLE, but possibly exerts
pathological effects, too. Our current ﬁndings thus support the necessity
of increased emphasis on brainstem and cerebellum in the research of
PD.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2015.08.008.
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